Word: biotechs
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
PLEADED GUILTY. SAMUEL WAKSAL, 54, Former chief executive of ImClone Systems, to insider-trading charges. Among them: telling his daughter to dump shares of his highflying biotech firm just before news broke that the FDA had rejected one of its cancer drugs. Waksal is trying to spare family members from prosecution. His plea might not help home diva Martha Stewart, also under investigation for improperly selling ImClone shares...
...Squadron. It's a good thing, then, that the hope of beating the Kiwis, who have held the Cup since 1995, enticed the fabulously rich to open their wallets. The competition includes teams funded by Oracle's Larry Ellison, Microsoft co-founder Paul Allen and telco investor Craig McCaw; biotech mogul Ernesto Bertarelli; shipping magnate Vincenzo Onorato; British tech millionaire Peter Harrison; and, of course, all the old and new money associated with the New York Yacht Club. After the first round robin in the famously capricious winds of Auckland's Hauraki Gulf, two of the highest-spending syndicates, OneWorld...
...felt the media attention surrounding her would "distract from the important work of the N.Y.S.E." Stewart had been elected to the board only four months earlier, shortly before allegations arose that she had participated in insider trading. Stewart sold all her shares of ImClone one day before the biotech company disclosed that its new cancer drug would not be approved by the Food and Drug Administration. Stewart has denied doing anything improper. But adding to her woes last week was the guilty plea entered by Douglas Faneuil, who was an assistant to Stewart's broker at Merrill Lynch. Faneuil admitted...
...Swedish biotech firm has signed an exclusive agreement with Harvard Medical School (HMS) that provides the firm broad access to nucleic acid technology developed...
...might be adding milk from a cloned cow to our coffee. Scientists, policymakers and others convene in Dallas this week to debate the possibility. That's because farmers and biotech firms are already cloning prize livestock. A National Academy of Sciences report says research vouches for the safety of by-products from cloned animals but calls for more study. If cloned animals end up in the food supply, will consumers know it? Probably not, says one of the report's authors, because "if companies can show that their milk or meat is substantially equivalent to those from noncloned animals...